Paxlovid decreased hospitalisation, risk of death during Omicron wave: Research
The research, published in the Canadian Medical Association Journal, aimed to evaluate the effectiveness of paxlovid, a…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ritonavir
Hetero’s ‘NIRMACOM’ gets WHO Prequalification for COVID-19 treatment
Hetero’s ‘NIRMACOM’ (Nirmatrelvir), a generic version of Pfizer’s COVID-19 oral antiviral drug ‘PAXLOVID’is co-packaged with…
WHO recommends Pfizer’s Paxlovid for wide geographical distribution
Pfizer’s oral antiviral drug (a combination of Nirmatrelvir and Ritonavir tablets) is strongly recommended for patients with…
‘TRIPS Waiver’ must be agreed now, says MSF
Access needs to be ensured for not just COVID-19 vaccines, but all COVID-19 medical tools, for everyone, everywhere
WHO to discontinue hydroxycholorquine trial for COVID-19
It said interim results show hydroxychloroquine “produce little or no reduction in the mortality of hospitalised COVID-19 patients…
Drug repurposing and its growing significance in India
Supreet Deshpande, CEO, NovaLead Pharma talks about how drug repurposing, with its priceless abilities to save time and millions…
New triple antiviral drugs combo shows promise against COVID-19: Study
Treatment involving a combination of the drugs interferon beta-1b, plus antiviral therapy lopinavir-ritonavir and ribavirin, is…